Telehealth General Psychiatry Prescribing: What Psychiatrists Can Do in California

If you’re a psychiatrist, PMHNP, or prescribing provider considering telehealth, you’ve probably wondered: Can I legally prescribe psychiatric medications—including controlled substances like Adderall or Xanax—through a video visit? The short answer in 2026 is yes, in most cases. But the details matter, because federal and state rules create a patchwork of requirements that can trip you up if you’re not careful.

This guide breaks down exactly what psychiatrists and psychiatric nurse practitioners can prescribe via telehealth, how the rules differ by state, and what you need to know to stay compliant while building a thriving virtual practice.

What Psychiatrists Can Prescribe via Telehealth in 2026

The Current Federal Landscape

Here’s the reality: since 2020, the DEA has allowed prescribers to initiate controlled substance prescriptions via telehealth without an initial in-person exam. This waiver—extended multiple times—remains in effect through at least December 31, 2025, and is widely expected to continue or be replaced with permanent flexibilities.

What this means practically: A psychiatrist can conduct a new patient evaluation via secure video and prescribe Schedule II stimulants (Adderall, Ritalin) for ADHD, benzodiazepines for anxiety, or buprenorphine for opioid use disorder—all without ever meeting the patient face-to-face. This has been a game-changer for access, especially in underserved areas where patients might wait months for an in-person appointment.

The catch: These are temporary federal rules. The DEA has proposed permanent regulations that could reimpose some in-person requirements or create special registration systems. Most experts expect the final rules to allow at least a 30-day initial prescription via telehealth before requiring in-person follow-up, but nothing is finalized yet. The smart play? Stay current on DEA announcements, but don’t let fear of future changes prevent you from serving patients today under current allowances.

State-Specific Variations

While federal law sets the baseline, states can add restrictions. The good news: most states have embraced telepsychiatry. Here’s what you need to know in key markets:

Florida explicitly permits controlled substance prescribing via telehealth for psychiatric treatment. The law carves out mental health from restrictions that apply to pain management—meaning a Florida-licensed psychiatrist can start a patient on stimulants or anxiety medications entirely online. This is one of the most provider-friendly telehealth laws in the country.

Texas allows telemedicine prescribing if the standard of care is met, but prohibits teleprescribing of opioids for chronic pain. For psychiatry, this isn’t usually an issue—you can prescribe ADHD medications, antidepressants, and anti-anxiety drugs via video visits. Texas does require checking the state’s Prescription Drug Monitoring Program (PMP) before prescribing any controlled substance, whether in-person or via telehealth.

New York recently aligned state rules with federal allowances. As of mid-2025, NYSDOH finalized regulations explicitly permitting controlled substance prescriptions via telehealth when federal law allows it. Prior state-level restrictions have been lifted, meaning NYC and upstate psychiatrists can confidently prescribe through video visits under current DEA waivers.

California takes a permissive approach: state law requires a ‘good faith exam’ before prescribing, but a telehealth video consultation counts as meeting that standard. California psychiatrists have been managing ADHD, anxiety, and depression entirely online since 2020, including initiating Schedule II medications. You must check CURES (California’s PMP) before prescribing controlled substances—this applies equally to telehealth and in-person visits.

Pennsylvania has no special state restrictions beyond federal requirements. During federal telehealth flexibilities, PA psychiatrists can prescribe controlled substances via video. The state does require e-prescribing for controlled medications and PMP checks, but these are standard compliance measures.

Illinois aligns with federal law. Psychiatrists with Illinois licenses can prescribe psychiatric medications via telehealth, including controlled substances under current DEA allowances. Illinois has been progressive on telehealth—the state mandates insurance reimbursement parity for tele-mental health through at least 2027.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Reality of Establishing a Patient-Physician Relationship

Every state requires a legitimate clinical relationship before prescribing. The question is: does telehealth count?

Yes—with proper standards. All the states above recognize an audio-visual telemedicine encounter as sufficient to establish the patient relationship and conduct an evaluation. The key requirements:

• Video is typically required for initial assessments, especially when prescribing controlled substances. Audio-only (phone) visits can work for established patients in some circumstances, and Medicare even covers audio-only mental health follow-ups for patients without video access—but for new patients and controlled substances, use video.

• Document appropriately: Note the platform used, patient location (state), consent obtained, and that you performed an adequate evaluation comparable to in-person standards. This isn’t just compliance theater—it’s your defense if a board ever questions the relationship.

• Emergency protocols matter: States like Texas require documented protocols for patient emergencies during telehealth (e.g., if a suicidal patient disconnects). Have a plan, document it, and make sure your platform allows you to collect emergency contact information.

The standard isn’t can you see them through a screen—it’s can you meet the same clinical standard you would in-office. If you can take a thorough history, perform a mental status exam, assess risk, and make an informed prescribing decision via video, you’re meeting the bar.

PMHNP vs. Psychiatrist: When Scope of Practice Limits Virtual Prescribing

Here’s where things get complicated if you’re a psychiatric nurse practitioner: your authority to prescribe via telehealth depends entirely on your state’s scope-of-practice laws.

Psychiatrists (MD/DO) have full independent prescribing authority in all 50 states. No collaboration agreements, no physician oversight, no formulary restrictions. If you’re a psychiatrist licensed in the state where your patient is located, you can prescribe any psychiatric medication (controlled or not) via telehealth under the rules outlined above.

PMHNPs face a state-by-state maze:

Full Practice Authority States (PMHNPs Can Prescribe Independently)

About 34 states now grant nurse practitioners full practice authority—meaning a PMHNP can evaluate, diagnose, and prescribe (including Schedule II-V medications) without physician oversight.

Examples: Washington, Oregon, Arizona, Colorado, Minnesota, and recently Massachusetts, Kansas, Indiana, Louisiana, and Michigan have all moved to full practice authority. In these states, a PMHNP with their own DEA number can manage the same telehealth cases as a psychiatrist.

New York is functionally full practice after a PMHNP completes 3,600 hours (roughly 2 years) of collaborative practice. After that threshold, they practice independently—no written agreement or chart review required. This has enabled many experienced PMHNPs in New York to open virtual practices serving underserved upstate regions.

Illinois requires 4,000 hours of collaboration plus 250 hours of continuing education before granting Full Practice Authority. Once achieved, Illinois PMHNPs can prescribe independently, including controlled substances for psychiatric conditions.

California is transitioning: as of 2023, NPs with 3+ years’ experience can practice without direct physician supervision in group settings (103 NP certification). By January 2026, those NPs can apply for full independent practice (104 NP), allowing them to open their own telehealth practices without physician oversight.

Restricted Practice States (PMHNPs Need Physician Collaboration)

Texas remains one of the most restrictive: PMHNPs cannot practice or prescribe without a Prescriptive Authority Agreement with a Texas-licensed physician. The physician doesn’t need to be on-site, but must meet with the NP regularly (monthly for the first 3 years, then quarterly) and the agreement must explicitly delegate prescribing authority.

The kicker in Texas: NPs generally cannot prescribe Schedule II controlled substances in outpatient settings, except in very narrow circumstances (terminal illness, certain pediatric ADHD cases with explicit protocols). For a telehealth ADHD practice, this means a Texas PMHNP typically cannot initiate stimulants—the collaborating psychiatrist often writes those prescriptions. Schedule III-V (like some anxiety meds) can be prescribed by the NP if delegated in the agreement.

One physician in Texas can supervise at most 7 NPs/PAs at once—this cap can create bottlenecks for telehealth companies trying to scale PMHNP services in the state.

Florida excludes psychiatric NPs from its autonomous practice law (which only covers primary care NPs). PMHNPs in Florida must practice under a supervising physician’s protocol. However, Florida defines ‘psychiatric nurses’ (PMHNPs with 2+ years’ experience under a psychiatrist) who can prescribe psychotropic controlled substances in collaboration with a psychiatrist—and they’re exempt from the 7-day Schedule II supply limit that applies to other NPs.

Practically: a Florida PMHNP can prescribe ADHD stimulants or anxiety medications via telehealth, but they need a collaborating psychiatrist and a written protocol on file.

Pennsylvania requires all NPs to maintain collaborative agreements indefinitely—no path to independence yet (though legislation is pending). A PA PMHNP can prescribe Schedule II controlled substances if the agreement explicitly allows it, but only in 30-day supplies initially, and the physician must be notified within 24 hours. Chart review requirements apply.

The Telehealth Multi-State Trap

If you’re practicing across state lines (which many telehealth providers do), remember: you must be licensed in the state where the patient is located, and you must follow that state’s scope-of-practice rules.

A PMHNP who has full practice authority in New York cannot simply treat patients in Texas and assume the same independence applies. You’d need a Texas license and a Texas collaborating physician to prescribe to Texas patients. This is where many telehealth NPs hit compliance issues—assuming their home state’s rules travel with them.

The Interstate Medical Licensure Compact (IMLC) helps psychiatrists get licensed in multiple states faster—Texas, Pennsylvania, and Illinois are members. But New York, Florida, and California aren’t, so you’ll go through traditional licensure processes there.

The APRN Compact (multi-state NP license) exists but is new and doesn’t override scope-of-practice laws. Even with a compact license, you still need to follow each state’s collaboration requirements. Texas joining the APRN Compact doesn’t eliminate the need for a collaborating physician in Texas.

How Reimbursement Works for Telehealth Medication Management

Now let’s talk money—because knowing the regulations is only half the equation. Can you actually get paid fairly for virtual med management?

The Good News: Telehealth Parity is Real

Thanks to pandemic-era policy changes that stuck, Medicare and most private insurers now reimburse telepsychiatry at the same rate as in-person visits. This is a massive shift from the pre-2020 landscape.

Medicare rates for 2026 (national averages):

• Initial psychiatric evaluation with medication management (CPT 90792): ~$173
• 15-minute med check follow-up (99213): ~$95
• 25-minute med check (99214): ~$136
• Longer/complex visit (99215): ~$192

These are the same whether you’re seeing the patient in your office or via secure video. Medicare uses place-of-service codes (POS-02 or modifier -95) to indicate telehealth, but payment is identical.

Private insurance typically pays more than Medicare—often $150-200 for routine follow-ups in high-cost areas. Many states (Illinois, California, New York) have laws mandating payment parity for telehealth mental health services, meaning insurers can’t reduce reimbursement just because the visit was virtual.

The NP Payment Gap: Medicare pays nurse practitioners at 85% of the physician fee schedule when services are billed under the NP’s own NPI. So a PMHNP would receive ~$81 for a 99213 that pays a psychiatrist $95. Some private payers follow this model; others credential NPs at full rates. This 15% gap can affect practice economics, which is why some telehealth platforms structure billing to have physicians handle initial evaluations (full rate) and NPs do follow-ups.

Medicaid varies by state but generally covers telepsychiatry. Florida Medicaid might pay $60-80 for a brief med check; California’s Medi-Cal pays closer to Medicare rates after recent rate increases. Most state Medicaid programs adopted telehealth parity during COVID and have kept it.

Audio-only visits (phone calls) are now reimbursed by Medicare for mental health services if the patient cannot access video. This is particularly useful for follow-up med checks with established patients in rural areas or those without smartphones. Private payers in states like Massachusetts and Illinois also cover audio-only behavioral health visits.

What This Means for Your Virtual Practice

The regulatory landscape has never been better for telepsychiatry, but compliance still requires attention to detail:

If you’re a psychiatrist:

• You can build a nationwide telehealth practice by obtaining licenses in multiple states (IMLC helps speed this up)
• You can prescribe virtually any psychiatric medication via video visits under current rules, including controlled substances
• Check each state’s PMP before prescribing controlled substances (all states require this)
• Document that you conducted an adequate exam via telehealth and obtained consent
• Stay alert for DEA rule changes, but don’t let uncertainty paralyze you—current allowances are solid through 2025 and likely beyond

If you’re a PMHNP:

• Verify your scope of practice in every state where you see patients—your home state’s rules don’t follow you
• In full practice states (NY, CA, IL, MA, many others), leverage your independence to build a practice comparable to psychiatrists
• In restricted states (TX, FL, PA), either work with a platform that provides collaborating physicians, or establish your own collaborative agreements before seeing patients
• Understand prescribing limitations (e.g., Texas Schedule II restrictions) and structure your practice accordingly—some PMHNPs focus on therapy + non-controlled med management and refer complex cases
• Consider practicing in multiple full-practice states to avoid bottlenecks from collaboration requirements

The Business Case for Telehealth Prescribing

Here’s the reality most providers don’t discuss openly: patient acquisition in psychiatry is expensive and time-consuming.

If you’re trying to build your own practice through traditional marketing, you’re looking at:

• SEO that takes 6-12 months to generate meaningful patient flow
• Google Ads for mental health keywords at $15-40+ per click (most clicks don’t convert)
• Psychology Today and Zocdoc listings where you compete with hundreds of local providers—and Zocdoc charges $35-100 per booked appointment on top of monthly fees
• When you factor in agency/consultant fees, ad spend optimization, staff time to qualify leads, and no-show rates from cold referrals, the true cost per acquired patient often hits $200-500+

The alternative: Join a telehealth platform that handles patient acquisition entirely.

Platforms like Klarity Health use a pay-per-appointment model where you pay a standard fee per new patient lead matched to your specialty and availability. You don’t spend thousands monthly on marketing with uncertain results—you pay only when a qualified patient books with you. That’s guaranteed ROI vs. gambling on marketing channels you may not have time or expertise to manage.

The value proposition is straightforward:

• No upfront marketing spend or monthly subscription fees draining your cash flow before you see a single patient
• Pre-qualified patients already matched to your specialty (ADHD, anxiety, depression) and schedule
• Built-in telehealth infrastructure—no separate platform costs, no IT headaches
• Both insurance and cash-pay patient flow, giving you volume without putting all eggs in one basket
• You control your schedule—only pay when you actually see patients, not for leads that don’t convert

For most providers, especially those starting out or scaling, the economics are simple: instead of spending $3,000-5,000/month on DIY marketing with uncertain results, you get predictable patient flow and pay only for appointments that happen.

Staying Compliant While Scaling

The most common compliance mistakes in telepsychiatry:

1. Treating patients in states where you’re not licensed: Every video visit must be billed under a license in the patient’s state. Period. No exceptions.

2. Assuming NP scope of practice is uniform: It’s not. A PMHNP who can prescribe independently in Oregon cannot do the same in Texas without a collaborating physician.

3. Forgetting PMP checks: Every state with a PMP requires checking it before prescribing controlled substances. Skipping this step is a board complaint waiting to happen.

4. Poor documentation of telehealth visits: Document the platform used, patient consent, emergency protocols, and that your exam met in-person standards. This protects you.

5. Ignoring DEA registration requirements: You need a DEA number in every state where you prescribe controlled substances. Some providers assume one DEA registration covers them everywhere—it doesn’t.

6. Not tracking state-specific changes: Scope-of-practice laws, telehealth rules, and controlled substance policies evolve constantly. Set calendar reminders to check state board websites quarterly.

The Bottom Line

Can psychiatrists prescribe medication through telehealth? Absolutely—and in 2026, you can do it at scale, with full reimbursement parity, including controlled substances under current federal allowances.

Can PMHNPs prescribe through telehealth? Yes, but your authority depends on where your patients are located and what your state’s collaboration laws require.

The regulatory environment has stabilized enough to make telepsychiatry a core practice model, not just a pandemic workaround. Psychiatrists and experienced PMHNPs in the right states can build thriving virtual practices managing ADHD, anxiety, depression, and other conditions entirely online.

The key is understanding the rules, maintaining licenses in your target states, and choosing a practice model that makes economic sense—whether that’s DIY marketing with all its upfront costs and uncertainty, or joining a platform that delivers qualified patients and handles the infrastructure while you focus on clinical care.

If you’re ready to leverage telehealth to grow your practice without the marketing gamble, explore joining Klarity Health’s provider network where psychiatrists and PMHNPs connect with patients who actually need psychiatric medication management—and you pay only when appointments happen.

Frequently Asked Questions

Can I prescribe Adderall or other Schedule II stimulants via telehealth?

Yes, under current federal rules (extended through at least December 31, 2025). Psychiatrists can initiate Schedule II stimulants like Adderall, Ritalin, or Vyvanse via video visits without an in-person exam. Check your state’s specific rules—some states like Texas have additional restrictions for PMHNPs prescribing Schedule II, but psychiatrists generally have full authority.

Do I need to meet patients in person before prescribing controlled substances?

Not currently. The DEA waived the in-person requirement during COVID and has extended these flexibilities multiple times. However, permanent DEA rules are pending—likely to be finalized in late 2024. Most expect some version of the current flexibility to continue, possibly requiring an in-person visit after an initial 30-day prescription. For now, you can prescribe controlled substances to new patients via telehealth.

What’s the difference between a psychiatrist and PMHNP prescribing via telehealth?

Psychiatrists have full independent prescribing authority in all states—no collaboration required. PMHNPs’ authority varies by state: in full practice authority states (like NY, CA, IL, MA), experienced PMHNPs can prescribe independently just like psychiatrists. In restricted states (TX, FL, PA), PMHNPs need physician collaboration agreements and may face limitations on certain controlled substances (especially Schedule II). Always verify scope of practice in the state where your patient is located.

Does insurance pay the same for telehealth visits as in-person?

In most cases, yes. Medicare pays telepsychiatry at the same rates as in-office visits, and most states have enacted payment parity laws requiring private insurers to do the same for mental health services. States like California, Illinois, and New York have strong parity statutes. Some variation exists in Medicaid, but generally telepsychiatry reimbursement is on par with in-person care in 2026.

Can I see patients in multiple states via telehealth?

Yes, but you must hold a valid medical license in every state where your patients are located during the video visit. The Interstate Medical Licensure Compact (IMLC) helps physicians get licensed faster in member states (Texas, Pennsylvania, Illinois are members; California, New York, Florida are not). Each state’s prescribing rules apply to patients in that state—so verify scope-of-practice requirements before treating patients across state lines.

Do I need a DEA number for every state where I prescribe?

Yes. You need a DEA registration for each state where you prescribe controlled substances. Your DEA number includes a state-specific suffix. When practicing telehealth across multiple states, you’ll need separate DEA registrations for each. This applies to both psychiatrists and PMHNPs.

Can I do medication management visits over the phone (audio-only)?

For established patients, yes—Medicare and many private payers now cover audio-only mental health visits when video isn’t available. This is particularly useful for brief follow-up med checks in rural areas or with patients who lack video technology. However, for new patients and initial controlled substance prescriptions, video is typically required to meet the standard of care and federal/state exam requirements.

What happens if the DEA changes the rules on teleprescribing?

The DEA has proposed permanent regulations that could modify current flexibilities. Most industry experts expect some form of telehealth prescribing to remain legal—possibly requiring an in-person visit after an initial prescription, or within a certain timeframe. The psychiatric community has lobbied heavily to maintain access, given workforce shortages. Stay updated through professional associations (APA, AANP) and your state medical/nursing board. Don’t let fear of future changes prevent you from building telehealth capabilities now—current rules are solid through 2025 at minimum.

References and Sources

1. California Board of Registered Nursing – AB 890 Implementation (Nov 2023): Official guidance on 103 NP and 104 NP certification pathways for independent practice. www.rn.ca.gov

2. Texas Board of Nursing – APRN Practice FAQ (Revised 2021): Primary source for Texas PMHNP collaboration requirements and prescriptive authority agreements. www.bon.texas.gov

3. National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates’ (Aug 2025): Comprehensive analysis of DEA telemedicine waivers and state-level controlled substance prescribing rules. natlawreview.com

4. Florida Statutes Chapter 464 – Nursing Practice Act (2024): Official state law governing PMHNP scope of practice, controlled substance prescribing limits, and telehealth provisions for psychiatric treatment. www.flsenate.gov

5. JD Supra – ‘New Law Allows Experienced NPs to Practice Without Collaborative Relationship’ (April 2022): Details New York’s 2022 budget amendments granting full practice authority to NPs after 3,600 hours. www.jdsupra.com

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship